Authors:
Kerman, RH
Katz, SM
Van Buren, CT
Garcia, C
Kahan, BD
Citation: Rh. Kerman et al., Addition of rapamycin to cyclosporine-prednisone based immunosuppression reduces the clinical risk of pretransplant anti-HLA antibody, TRANSPLAN P, 33(1-2), 2001, pp. 401-401
Authors:
Kahan, BD
Welsh, M
Urbauer, DL
Mosheim, MB
Beusterien, KM
Wood, MR
Schoenberg, LP
Dicesare, J
Katz, SM
Van Buren, CT
Citation: Bd. Kahan et al., Low intraindividual variability of cyclosporin A exposure reduces chronic rejection incidence and health care costs, J AM S NEPH, 11(6), 2000, pp. 1122-1131
Authors:
Kahan, BD
Wong, RL
Carter, C
Katz, SH
Von Fellenberg, J
Van Buren, CT
Appel-Dingemanse, S
Citation: Bd. Kahan et al., A phase I study of a 4-week course of SDZ-RAD (RAD) in quiescent cyclosporine-prednisone-treated renal transplant recipients, TRANSPLANT, 68(8), 1999, pp. 1100-1106
Authors:
Kerman, RH
Susskind, B
Buyse, I
Pryzbylowski, P
Ruth, J
Warnell, S
Gruber, SA
Katz, S
Van Buren, CT
Kahan, BD
Citation: Rh. Kerman et al., Flow cytometry-detected IgG is not a contraindication to renal transplantation - IgM may be beneficial to outcome, TRANSPLANT, 68(12), 1999, pp. 1855-1858
Authors:
Kerman, RH
Susskind, B
Ruth, J
Katz, S
Van Buren, CT
Kahan, BD
Citation: Rh. Kerman et al., Can an immunologically, nonreactive potential allograft recipient undergo transplantation without a donor-specific crossmatch?, TRANSPLANT, 66(12), 1998, pp. 1833-1834
Citation: Al. Caplan et al., Financial compensation for cadaver organ donation: Good idea or anathema?, ETHICS OF ORGAN TRANSPLANTS: THE CURRENT DEBATE, 1998, pp. 219-223